SEC Form 4 · accession 0001615594-15-000009
MGC DIAGNOSTICS Corp · MGCD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hendrik Struik
Director
Period of report
Jan 12, 2015
Accepted (ET)
Jan 20, 2015 · 2:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815093
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 12, 2015 | P | 204 | $6.00 | A | 22,258 | D | |
| Common StockF2 | Jan 13, 2015 | P | 1,659 | $6.25 | A | 23,917 | D | |
| Common StockF3 | Jan 14, 2015 | P | 1,900 | $6.22 | A | 25,817 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price and is exclusive of brokerage fees. The shares were purchased in multiple transactions at prices ranging from $5.98 to $6.00, inclusive. The reporting person undertakes to provide MGC Diagnostics Corporation, any security holder of MGC Diagnostics Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
- F2The price reported in Column 4 is a weighted average price and is exclusive of brokerage fees. The shares were purchased in multiple transactions at prices ranging from $6.19 to $6.35.
- F3The price reported in Column 4 is a weighted price and is exclusive of brokerage fees. The shares were purchased in multiple transactions at prices ranging from $6.08 to $6.35.